Sort
48,018 grants matching “immunotherapy”
Biospecimen Unit
$1,241,085Bruce E. Johnson · Dana-Farber Cancer Inst · U2C · FY2023 · CA
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,240,321Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Immunologic Correlates of Immunization for Cancer
$1,240,135University Of Washington · U54 · FY2003 · CA
Novel Molecular Therapies of Prostate Cancer
$1,239,835Dario C. Altieri · Wistar Institute · P01 · FY2017 · CA
The effect of peptide therapy and allergen provocation on Fel d1-specific T Cells
$1,239,733Mark Larche · Mcmaster University · U19 · FY2015 · AI
Novel focused ultrasound enhanced calreticulin-nanoparticle for immune primed melanoma immunotherapy
$1,239,509Ashish Ranjan · Ut Southwestern Medical Center · R37 · FY2025 · CA
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning
$1,238,429Konstantin Ichtchenko · New York University School Of Medicine · R01 · FY2015 · AI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning
$1,238,429Konstantin Ichtchenko · New York University School Of Medicine · R01 · FY2016 · AI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning
$1,238,429Konstantin Ichtchenko · New York University School Of Medicine · R01 · FY2012 · AI
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma
$1,237,901Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
A turnkey research platform to accelerate clinical translation of targeted immune-modulation enhanced therapies
$1,237,360Ryan Gessner · Sonovol, Inc. · R44 · FY2021 · CA
Novel SCD1 inhibitors for treatment of cancer
$1,236,819John A Copland · Modulation Therapeutics, Inc. · R42 · FY2019 · CA
Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay
$1,236,637Yun Wu · State University Of New York At Buffalo · R01 · FY2025 · CA
The effect of peptide therapy and allergen provocation on Fel d1-specific T Cells
$1,236,590Mark Larche · Mcmaster University · U19 · FY2016 · AI
Sirtuin -Dependent Regulation of Tuberculosis and HIV Interactions in Macrophages
$1,236,573Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2025 · AI
Development of Novel sgp130-Fc Bioconjugates for TBI
$1,236,188William E Haskins · Gryphon Bio, Inc. · R44 · FY2025 · NS
Surgery Branch Cell Prep Core
$1,236,025John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Cell Production Core Facility
$1,236,025Robert Somerville · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Pig-to-Monkey Islet Xenotransplantation
$1,234,462Bernhard Josef Hering · University Of Minnesota · U01 · FY2018 · AI
First-in-human clinical trial of proprietary oral gel to treat radiation-induced oral mucositis in cancer patients
$1,233,852Christian Young · Allander Biotechnologies, Inc. · R44 · FY2025 · CA
SPORE In Prostate Cancer
$1,233,307William George Nelson · Johns Hopkins University · P50 · FY2013 · CA
Programming T Cell Fates for Therapeutic Use
$1,233,165Luca Gattinoni · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
U.T. SOUTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT
$1,232,598University Of Texas Sw Med Ctr/Dallas · U01 · FY2002 · AI
iPS cell based immunotherapy for malignant gliomas
$1,231,643John Park · National Institute Of Neurological Disorders And Stroke · ZIA · FY2013 · NS
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$1,231,558Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL